Federal Circuit: Jury Should Have Found Eyelash Med Patent Claim Invalid
WASHINGTON, D.C. — A Federal Circuit U.S. Court of Appeals panel said on Nov. 18 that a generic drug maker “has overcome the doubly high burden of persuading us to overturn...To view the full article, register now.
Already a subscriber? Click here to view full article